Shorted
Monash Ivf Group logo
MVF
Health Care Equipment & Services

Monash Ivf Group

Short interest
1.45%
−0.01 pp 30d
as of 13 Oct 2026
Reported shorts
5.6M
Shares on issue
389.635M

Monash Ivf Group (MVF) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
2 Sept

Why Is Monash IVF Group Limited (ASX:MVF) in Focus?

Highlights The fertility services provider advanced again as the market digested its full year numbers. Several research desks refreshed their ratings following the result release. Health care was the only defensive sector to finish ahead on the session. Monash IVF Group Limited (ASX:MVF) extended its post-result bounce on Tuesday as the market continued absorbing full year numbers released the previous session, with several research desks refreshing their views and lifting a fertility servic...

Continue reading
Kalkine
Neutral
1 Sept

Why Is Monash IVF (ASX:MVF) in Focus Among Smallcap Stocks?

Highlights The fertility services group reported a sharp fall in annual profit, landing beneath its own revised guidance range for the year. Softer domestic stimulated cycle volumes drove the shortfall, partly offset by growth across international, genetics and ancillary revenue streams. A final fully franked distribution was declared, and corporate interest in the company remains an unresolved thread in the story. Monash IVF Group (ASX:MVF), the Melbourne-headquartered fertility services pro...

Continue reading
Kalkine
Neutral
1 Sept

Can Monash IVF (ASX:MVF) Remain a Leading Name Among Healthcare Stocks?

Highlights Monash IVF reported a sharp fall in annual profit, landing beneath its revised guidance range. Offshore revenue and specialist genetics testing delivered record contributions across the year. Domestic stimulated cycle volumes steadied in the second half after a soft opening stretch. Monash IVF Group (ASX:MVF), the listed fertility services operator with clinics across Australia and South-East Asia, closed out the annual reporting calendar with a result that fell short of its own re...

Continue reading
Kalkine
Neutral
31 Aug

Monash IVF Group Submits Appendix 4G Highlighting Corporate Governance Compliance for FY2026

Monash IVF Group Limited (ASX:MVF) has filed its Appendix 4G Key to Disclosures document with the ASX for the financial year ending 30 June 2026, confirming that the company's corporate governance statement was board-approved and remains accurate as of 21 August 2026. Key Points Monash IVF Group submitted its Appendix 4G for FY ended 30 June 2026 The corporate governance statement is available on the company website and received board approval as of 21 August 2026 Rebecca Dean, Company Secret...

Continue reading
Kalkine
Positive
23 June

Monash IVF (ASX:MVF): Why This Healthcare Dividend Stock Faces a New Test

Highlights Monash IVF recently updated its earnings outlook following softer fertility treatment activity in Australia. The company continues to operate within the growing reproductive healthcare sector despite near-term industry challenges. Demand trends, demographic shifts and healthcare accessibility remain important themes shaping the sector. Monash IVF remains under the spotlight as industry activity trends and broader economic conditions influence Australia's fertility services market. ...

Continue reading
Kalkine
Neutral
15 June

Half Its Previous Value: Can Monash IVF Stage a Recovery

Highlights Monash IVF continues to face challenging operating conditions across the Australian fertility market. Recent market share improvements have provided a positive development amid broader sector pressures. Growth in international operations is emerging as an important area of focus. Monash IVF is showing signs of stabilisation through market share gains and international growth despite ongoing challenges across the fertility treatment sector. Australian healthcare stocks have experien...

Continue reading
Kalkine
Neutral
13 Apr

Is Monash IVF Near a Deal as Takeover Pressure Builds?

Highlights Revised takeover proposal places valuation under spotlight Consortium’s existing stake shapes ongoing discussions Board weighs certainty against long-term recovery outlook A renewed takeover proposal has brought Monash IVF Group Ltd (MVF) back into focus, with the board assessing improved terms while balancing near-term certainty against long-term growth prospects. A Fresh Bid Rekindles Market Attention The fertility services sector has re-entered the spotlight as Monas...

Continue reading